| 1 |
33297669 |
10.3324/haematol.2020.267294 |
2022 |
Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas. |
TET2 |
| 2 |
33579790 |
10.1136/gutjnl-2020-322935 |
2022 |
Oncogenetic landscape of lymphomagenesis in coeliac disease. |
TET2 |
| 3 |
34494161 |
10.1007/s00428-021-03186-3 |
2022 |
Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin. |
TET2 |
| 4 |
34840089 |
10.1016/j.clml.2021.10.015 |
2022 |
Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations. |
TET2 |
| 5 |
34847227 |
10.1182/bloodadvances.2021004926 |
2022 |
Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenström macroglobulinemia. |
TET2 |
| 6 |
34937926 |
10.1038/s41590-021-01087-w |
2022 |
TET deficiency perturbs mature B cell homeostasis and promotes oncogenesis associated with accumulation of G-quadruplex and R-loop structures. |
TET2 |
| 7 |
34980830 |
10.1097/PAS.0000000000001859 |
2022 |
Clinicopathologic and Genetic Features of Primary T-cell Lymphomas of the Central Nervous System: An Analysis of 11 Cases Using Targeted Gene Sequencing. |
TET2 |
| 8 |
34998786 |
10.1016/j.clml.2021.12.008 |
2022 |
The Application of NextGen Sequencing in the Diagnosis of Myeloid Neoplasms in Myeloma Patients With Cytopenia. |
TET2 |
| 9 |
35021606 |
10.3324/haematol.2021.280003 |
2022 |
Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS. |
TET2 |
| 10 |
35064935 |
10.1111/his.14619 |
2022 |
Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis. |
TET2 |
| 11 |
35255774 |
10.1080/15548627.2022.2048432 |
2022 |
TET2 regulates osteoclastogenesis by modulating autophagy in OVX-induced bone loss. |
TET2 |
| 12 |
35256801 |
10.1038/s41591-022-01708-3 |
2022 |
High burden of clonal hematopoiesis in first responders exposed to the World Trade Center disaster. |
TET2 |
| 13 |
35301414 |
10.1038/s41379-022-01022-w |
2022 |
Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations. |
TET2 |
| 14 |
35380239 |
10.1007/s00277-022-04806-x |
2022 |
The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation. |
TET2 |
| 15 |
35401516 |
10.3389/fimmu.2022.842439 |
2022 |
Oncogenic Mutations and Tumor Microenvironment Alterations of Older Patients With Diffuse Large B-Cell Lymphoma. |
TET2 |
| 16 |
35459873 |
10.1038/s41375-022-01571-8 |
2022 |
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma. |
TET2 |
| 17 |
35492814 |
10.1016/j.jaccao.2022.01.098 |
2022 |
<i>TET2</i> Clonal Hematopoiesis Is Associated With Anthracycline-Induced Cardiotoxicity in Patients With Lymphoma. |
TET2 |
| 18 |
35533245 |
10.1158/2643-3230.BCD-21-0177 |
2022 |
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma. |
TET2 |
| 19 |
35543621 |
10.1080/10428194.2022.2070913 |
2022 |
Predictive and prognostic value of gene mutations in myelodysplastic syndrome treated with hypomethylating agents: a meta-analysis. |
TET2 |
| 20 |
35577752 |
10.1016/j.clml.2022.04.015 |
2022 |
Epigenetic Aberrations and Targets in Peripheral T-Cell Lymphoma. |
TET2 |
| 21 |
35590059 |
10.1038/s43018-022-00370-5 |
2022 |
Acute lymphoblastic leukemia displays a distinct highly methylated genome. |
TET2 |
| 22 |
35625998 |
10.3390/cancers14102392 |
2022 |
Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality. |
TET2 |
| 23 |
35652795 |
10.1080/10428194.2022.2081323 |
2022 |
The characteristics and clinical prognosis analysis of ASXL1 mutations in Chinese adult patients with primary cytogenetically normal acute myeloid leukemia by next-generation sequencing. |
TET2 |
| 24 |
35835912 |
10.1038/s41588-022-01121-z |
2022 |
Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis. |
TET2 |
| 25 |
35846192 |
10.1002/jha2.354 |
2022 |
T-cell lymphoma, B-cell lymphoma, and myelodysplastic syndrome harboring common mutations: Trilineage tumorigenesis from a common founder clone. |
TET2 |
| 26 |
35895386 |
10.1111/bjd.21791 |
2022 |
Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study. |
TET2 |
| 27 |
35921527 |
10.1182/blood.2022015451 |
2022 |
Clonal germinal center B cells function as a niche for T-cell lymphoma. |
TET2 |
| 28 |
35995702 |
10.1016/j.clml.2022.07.009 |
2022 |
Real-World Efficacy of 5-Azacytidine as Salvage Chemotherapy for Angioimmunoblastic T-cell Lymphoma. |
TET2 |
| 29 |
36012614 |
10.3390/ijms23169349 |
2022 |
Angioimmunoblastic T-Cell Lymphoma with Exuberant CD30-Positive Follicular Dendritic Cell Proliferation in a SARS-CoV-2 Patient: The Role of Mutational Analysis to Exclude an Associated Follicular Dendritic Cell Sarcoma. |
TET2 |
| 30 |
36048893 |
10.1093/ajcp/aqac104 |
2022 |
Systemic Presentation of Somatic TET2 Mutated B-Cell Lymphoma in a Child With Kabuki Syndrome and a Germline KMT2D Variant. |
TET2 |
| 31 |
36059252 |
10.1080/10428194.2022.2116932 |
2022 |
MDM2 antagonist improves therapeutic activity of azacitidine in myelodysplastic syndromes and chronic myelomonocytic leukemia. |
TET2 |
| 32 |
36066697 |
10.1007/s10875-022-01361-y |
2022 |
Novel Germline TET2 Mutations in Two Unrelated Patients with Autoimmune Lymphoproliferative Syndrome-Like Phenotype and Hematologic Malignancy. |
TET2 |
| 33 |
33413063 |
10.2174/1568009620666210106122750 |
2021 |
Epigenetic Mechanisms of Therapy Resistance in Diffuse Large B Cell Lymphoma (DLBCL). |
TET2 |
| 34 |
33431788 |
10.1038/s41392-020-00437-8 |
2021 |
CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis. |
TET2 |
| 35 |
33432228 |
10.1038/s41590-020-00827-8 |
2021 |
Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation. |
TET2 |
| 36 |
33496747 |
10.1182/bloodadvances.2020003081 |
2021 |
Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma. |
TET2 |
| 37 |
33512451 |
10.1182/blood.2020006721 |
2021 |
Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells. |
TET2 |
| 38 |
33544565 |
10.1097/PAS.0000000000001658 |
2021 |
Immunophenotypic Spectrum and Genomic Landscape of Refractory Celiac Disease Type II. |
TET2 |
| 39 |
33546774 |
10.1186/s40164-021-00200-x |
2021 |
Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomas. |
TET2 |
| 40 |
33569430 |
10.21037/atm-20-7574 |
2021 |
Molecular profiling of Chinese systemic anaplastic large cell lymphoma patients: novel evidence of genetic heterogeneity. |
TET2 |
| 41 |
33650043 |
10.1007/s00428-021-03071-z |
2021 |
Clinicopathological characterization of follicular helper T-cell-derived peripheral T-cell lymphoma involving Waldeyer's ring. |
TET2 |
| 42 |
33708776 |
10.3389/fmed.2021.584507 |
2021 |
Case Report: Refusal of an Veno-Arterial Extracorporeal Membrane Oxygenation Due to Malignant Disease? - An Extremely Rare Form of Cardiac Involvement in Acute Myeloid Leukemia. |
TET2 |
| 43 |
33711909 |
10.1080/10428194.2021.1894650 |
2021 |
Mutational spectrum of <i>de novo NPM1</i>-mutated acute myeloid leukemia patients older than 75 years. |
TET2 |
| 44 |
33739791 |
10.1097/PAS.0000000000001646 |
2021 |
Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome. |
TET2 |
| 45 |
33829512 |
10.1111/his.14378 |
2021 |
Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma. |
TET2 |
| 46 |
33849798 |
10.1016/j.clml.2021.03.002 |
2021 |
Clinicopathological Implications of RHOA Mutations in Angioimmunoblastic T-Cell Lymphoma: A Meta-analysis: RHOA mutations in AITL. |
TET2 |
| 47 |
33876209 |
10.1182/blood.2020010510 |
2021 |
14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia. |
TET2 |
| 48 |
33928261 |
10.1038/s43018-020-00161-w |
2021 |
<i>FYN-TRAF3IP2</i> induces NF-κB signaling-driven peripheral T cell lymphoma. |
TET2 |
| 49 |
33939500 |
10.1177/10668969211013402 |
2021 |
A Pedigree Analysis and Clonal Correlations of the Coexistence of B-Cell Lymphoma and Histiocytic/Dendritic Cell Tumor. |
TET2 |
| 50 |
33941203 |
10.1186/s13045-021-01068-4 |
2021 |
Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL. |
TET2 |
| 51 |
33951889 |
10.3324/haematol.2020.271957 |
2021 |
MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma. |
TET2 |
| 52 |
33990228 |
10.1186/s40164-021-00224-3 |
2021 |
Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas. |
TET2 |
| 53 |
34021249 |
10.1038/s41375-021-01289-z |
2021 |
Thyroid MALT lymphoma: self-harm to gain potential T-cell help. |
TET2 |
| 54 |
34065087 |
10.3390/ijms22095013 |
2021 |
The Impact of Epigenetic Modifications in Myeloid Malignancies. |
TET2 |
| 55 |
34078586 |
10.1016/j.clml.2021.04.014 |
2021 |
Genetic Heterogeneity in Chronic Myeloid Leukemia: How Clonal Hematopoiesis and Clonal Evolution May Influence Prognosis, Treatment Outcome, and Risk of Cardiovascular Events. |
TET2 |
| 56 |
34108263 |
10.1158/1535-7163.MCT-20-0377 |
2021 |
Targeting the T-Cell Lymphoma Epigenome Induces Cell Death, Cancer Testes Antigens, Immune-Modulatory Signaling Pathways. |
TET2 |
| 57 |
34164626 |
10.1158/2643-3230.BCD-20-0203 |
2021 |
Dissecting Clonal Hematopoiesis in Tissues of Classical Hodgkin Lymphoma Patients. |
TET2 |
| 58 |
34230442 |
10.1097/CCO.0000000000000773 |
2021 |
Epigenetic focus on angioimmunoblastic T-cell lymphoma: pathogenesis and treatment. |
TET2 |
| 59 |
34258755 |
10.1111/bjh.17639 |
2021 |
Characteristics of genetic alterations of peripheral T-cell lymphoma in childhood including identification of novel fusion genes: the Japan Children's Cancer Group (JCCG). |
TET2 |
| 60 |
34272731 |
10.1111/bjh.17708 |
2021 |
EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features. |
TET2 |
| 61 |
34390161 |
10.1002/pbc.29285 |
2021 |
Molecular features of non-anaplastic peripheral T-cell lymphoma in children and adolescents. |
TET2 |
| 62 |
34413196 |
10.1073/pnas.2110758118 |
2021 |
TET2 as a tumor suppressor and therapeutic target in T-cell acute lymphoblastic leukemia. |
TET2 |
| 63 |
34424323 |
10.1182/bloodadvances.2021004653 |
2021 |
B-cell acute lymphoblastic leukemia in patients with germline RUNX1 mutations. |
TET2 |
| 64 |
34447369 |
10.3389/fimmu.2021.671755 |
2021 |
Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management. |
TET2 |
| 65 |
34449978 |
10.1002/dc.24861 |
2021 |
Angioimmunoblastic T-cell lymphoma diagnosed from pleural fluid by integration of morphologic, immunophenotypic, and molecular findings. |
TET2 |
| 66 |
34570179 |
10.1182/bloodadvances.2021004668 |
2021 |
Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies. |
TET2 |
| 67 |
34581268 |
10.7554/eLife.66395 |
2021 |
Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking. |
TET2 |
| 68 |
34590470 |
10.52586/4970 |
2021 |
Methylation alterations and advance of treatment in lymphoma. |
TET2 |
| 69 |
34615796 |
10.11406/rinketsu.62.1367 |
2021 |
[Epigenetic abnormalities in non-Hodgkin lymphomas]. |
TET2 |
| 70 |
34621263 |
10.3389/fimmu.2021.688493 |
2021 |
Cohesin Core Complex Gene Dosage Contributes to Germinal Center Derived Lymphoma Phenotypes and Outcomes. |
TET2 |
| 71 |
34899857 |
10.3389/fgene.2021.768913 |
2021 |
Epigenetic Regulation of miR-92a and TET2 and Their Association in Non-Hodgkin Lymphoma. |
TET2 |
| 72 |
35008340 |
10.3390/cancers14010176 |
2021 |
Recent Advances in the Genetic of MALT Lymphomas. |
TET2 |
| 73 |
35027991 |
|
2021 |
Update on recurrent mutations in angioimmunoblastic T-cell lymphoma. |
TET2 |
| 74 |
31028364 |
10.1038/s41379-019-0279-8 |
2020 |
Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified. |
TET2 |
| 75 |
31827242 |
10.1038/s41375-019-0675-6 |
2020 |
Familial myeloid malignancies with germline TET2 mutation. |
TET2 |
| 76 |
31859368 |
10.1002/path.5376 |
2020 |
Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell. |
TET2 |
| 77 |
31870198 |
10.1080/10428194.2019.1702179 |
2020 |
Angioimmunoblastic T-cell lymphoma in Taiwan reveals worse progression-free survival for <i>RHOA</i> G17V mutated subtype. |
TET2 |
| 78 |
31896782 |
10.1038/s41375-019-0697-0 |
2020 |
The clinical mutatome of core binding factor leukemia. |
TET2 |
| 79 |
32077355 |
10.1080/10428194.2020.1728751 |
2020 |
Longitudinal clonal architecture of acute myeloid leukemia with <i>NPM1</i> driver insertion, early <i>TET2</i> mutations and secondary e6a2 <i>BCR-ABL1</i> rearrangement. |
TET2 |
| 80 |
32091281 |
10.1080/10428194.2020.1723016 |
2020 |
Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated <i>RUNX1</i> versus acute myeloid leukemia with myelodysplasia-related changes with mutated <i>RUNX1</i>. |
TET2 |
| 81 |
32107212 |
10.1158/0008-5472.CAN-19-2787 |
2020 |
Dasatinib Is an Effective Treatment for Angioimmunoblastic T-cell Lymphoma. |
TET2 |
| 82 |
32114498 |
10.1136/jitc-2019-000104 |
2020 |
T-cell lymphoma secondary to checkpoint inhibitor therapy. |
TET2 |
| 83 |
32127923 |
10.1177/1758835919900856 |
2020 |
Epigenetic aberrations in natural killer/T-cell lymphoma: diagnostic, prognostic and therapeutic implications. |
TET2 |
| 84 |
32187361 |
10.1182/blood.2019003535 |
2020 |
Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report. |
TET2 |
| 85 |
32203209 |
10.1038/s41416-020-0788-8 |
2020 |
Decreased vitamin C uptake mediated by SLC2A3 promotes leukaemia progression and impedes TET2 restoration. |
TET2 |
| 86 |
32239385 |
10.1007/s11523-020-00710-4 |
2020 |
Genomic Alterations and MYD88<sup>MUT</sup> Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib. |
TET2 |
| 87 |
32271188 |
10.1097/PAS.0000000000001470 |
2020 |
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders: A Clinical, Pathologic, and Molecular Study of 60 Cases Presenting With a Single Lesion: A Multicenter Study of the French Cutaneous Lymphoma Study Group. |
TET2 |
| 88 |
32397113 |
10.3390/ijms21093323 |
2020 |
Identification of Lenalidomide Sensitivity and Resistance Mechanisms in Non-Del(5q) Myelodysplastic Syndromes. |
TET2 |
| 89 |
32442302 |
10.1182/bloodadvances.2020001636 |
2020 |
Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms. |
TET2 |
| 90 |
32469082 |
10.1002/cncr.32866 |
2020 |
Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma. |
TET2 |
| 91 |
32518946 |
10.1182/blood.2020005844 |
2020 |
Germline TET2 loss of function causes childhood immunodeficiency and lymphoma. |
TET2 |
| 92 |
32598477 |
10.1182/bloodadvances.2019001350 |
2020 |
Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis. |
TET2 |
| 93 |
32853377 |
10.1182/blood.2020006881 |
2020 |
Human TET2 bridges cancer and immunity. |
TET2 |
| 94 |
32945366 |
10.3892/ijmm.2020.4686 |
2020 |
A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital image analysis. |
TET2 |
| 95 |
33106431 |
10.1073/pnas.2014308117 |
2020 |
A mosaic analysis system with Cre or Tomato expression in the mouse. |
TET2 |
| 96 |
33160401 |
10.1186/s13148-020-00962-x |
2020 |
Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma. |
TET2 |
| 97 |
33167720 |
10.1080/10428194.2020.1779255 |
2020 |
Venetoclax induced complete remission in extramedullary relapse of AML co-harboring <i>NPM1</i>, <i>TET2</i>, and <i>NRAS</i> mutations after haploidentical hematopoietic stem cell transplantation. |
TET2 |
| 98 |
33224395 |
10.14740/jh760 |
2020 |
Molecular Genetic Analysis With Flow Cytometry Sorting Identifies Angioimmunoblastic T-Cell Lymphoma and Concomitant <i>De Novo</i> Myelodysplastic Syndrome Arising From the Same Hematopoietic Progenitor. |
TET2 |
| 99 |
33363958 |
10.1002/ccr3.3430 |
2020 |
Angioimmunoblastic T-cell lymphoma after acute myeloid leukemia: Alleged common pathogenesis. A case report and literature review. |
TET2 |
| 100 |
33376237 |
10.1038/s41392-020-00331-3 |
2020 |
Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma. |
TET2 |
Datasets
Models
